Activation of AMP-activated protein kinase inhibits the proliferation of human endothelial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 3, 2012, Pages 827-834

  Peyton, Kelly J ^a   Liu, Xiao Ming ^a   Yu, Yajie ^a   Yates, Benjamin ^a   Durante, William ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; CYCLIN A; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; NITRIC OXIDE SYNTHASE; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANGIOGENESIS; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN A; ENZYME ACTIVATION; G0 PHASE; G1 PHASE; HEME OXYGENASE-1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PYRONES; RETINOBLASTOMA PROTEIN; RIBONUCLEOTIDES; THIOPHENES;

EID: 84865165917     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.194712     Document Type: Article

References (52)

1. Colombo SL and Moncada S (2009) AMPKα1 regulates the antioxidant status of vascular endothelial cells. Biochem J 421:163-169.
2. Corton JM, Gillespie JG, Hawley SA, and Hardie DG (1995) 5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558-565.
3. Davis BJ, Xie Z, Viollet B, and Zou MH (2006) Activation of the AMP-activated kinase by antidiabetes drug metformin stimulate nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 55:496-505. (Pubitemid 43343281)
4. Drummond GS and Kappas A (1981) Prevention of neonatal hyperbilirubinemia by tin protoporphyin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A 78:6466-6470. (Pubitemid 12179733)
5. El-Mir MY, Nogueira V, Fontaine E, Avéret N, Rigoulet M, and Leverve X (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275:223-228. (Pubitemid 30038975)
6. Esfahanian N, Shakiba Y, Nikbin B, Soraya H, Maleki-Dizaji N, Ghazi-Khansari M, and Garjani A (2012) Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells. Mol Med Report 5:1068-1074.
7. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, and Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330:1304-1305. (Pubitemid 40813563)
8. Ewart MA, Kohlhaas CF, and Salt IP (2008) Inhibition of tumor necrosis factor α-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase. Arterioscler Thromb Vasc Biol 28:2255-2257.
9. Folkman J (2006) Angiogenesis. Annu Rev Med 57:1-18.
10. ATP channels and heme oxygenase. Microcirculation 16:167-176.
11. Gaskin FS, Kamada K, Yusof M, and Korthuis RJ (2007) 5′-AMP- activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 292:H326-H332. (Pubitemid 46105194)
12. Göransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, Viollet B, Hardie DG, and Sakamoto K (2007) Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem 282:32549-32560. (Pubitemid 350159310)
13. Hardie DG, Hawley SA, and Scott JW (2006) AMP-activated protein kinase-development of the energy sensor concept. J Physiol 574:7-15. (Pubitemid 43905792)
14. Hattori Y, Suzuki K, Hattori S, and Kasai K (2006) Metformin inhibits cytokine-induced nuclear factor κB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 47:1183-1188. (Pubitemid 44289177)
15. Hawley SA, Ross FA, Chevtzoff C, Green KA, Evans A, Fogarty S, Towler MC, Brown LJ, Ogunbayo OA, Evans AM, et al. (2010) Use of cells expressing γ subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab 11:554-565.
16. Henderson JF, Paterson AR, Caldwell IC, Paul B, Chan MC, and Lau KF (1972) Inhibitors of nucleoside and nucleotide metabolism. Cancer Chemother Rep 2 3:71-85.
17. Ido Y, Carling D, and Ruderman N (2002) Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 51:159-167. (Pubitemid 34517993)
18. Imamura K, Ogura T, Kishimoto A, Kaminishi M, and Esumi H (2001) Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun 287:562-567. (Pubitemid 32917636)
19. Ishii N, Matsumura T, Kinoshita H, Motoshima H, Kojima K, Tsutsumi A, Kawasaki S, Yano M, Senokuchi T, Asano T, et al. (2009) Activation of AMPK-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation. J Biol Chem 284:34561-34569.
20. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, and Thompson CB (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18:283-293. (Pubitemid 41350534)
21. Kanellis J, Kandane RK, Etemadmoghadam D, Fraser SA, Mount PF, Levidiotis V, Kemp BE, and Power DA (2006) Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cells. Immunol Cell Biol 84:6-12.
22. Kodiha M, Ho-Wo-Cheong D, and Stochaj U (2011) Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology. Am J Physiol Cell Physiol 301:C1307-C1315.
23. Kubota S, Ozawa Y, Kurihara T, Sasaki M, Yuki K, Miyake S, Noda K, Ishida S, and Tsubota K (2011) Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Invest Ophthalmol Vis Sci 52:9142-9148.
24. Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, and Bilo HJ (2010) Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33:322-326.
25. Li D, Wang D, Wang Y, Ling W, Feng X, and Xia M (2010) Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice. J Biol Chem 285:33499-33509.
26. Li D, Yeung SC, Hassan MM, Konopleva M, and Abbruzzese JL (2009a) Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137:482-488.
27. Li X, Han Y, Pang W, Li C, Xie X, Shyy JY, and Zhu Y (2008) AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:1789-1795.
28. Li XN, Song J, Zhang L, LeMaire SA, Hou X, Zhang C, Coselli JS, Chen L, Wang XL, Zhang Y, et al. (2009b) Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 58:2246-2257.
29. Liu XM, Peyton KJ, Shebib AR, Wang H, Korthuis RJ, and Durante W (2011) Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 300:H84-H93.
30. Morrow VA, Foufelle F, Connell JM, Petrie JR, Gould GW, and Salt IP (2003) Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem 278:31629-31639. (Pubitemid 37048341)
31. Nagata D, Mogi M, and Walsh K (2003) AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 278:31000-31006. (Pubitemid 36994613)
32. Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, and Hirata Y (2004) AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 110:444-451. (Pubitemid 38993855)
33. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, and Walsh K (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279:1304-1309. (Pubitemid 38082655)
34. Palmer RM, Rees DD, Ashton DS, and Moncada S (1988) L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153:1251-1256.
35. Peyton KJ, Ensenat D, Azam MA, Keswani AN, Kannan S, Liu XM, Wang H, Tulis DA, and Durante W (2009) Arginase promotes neointima formation in rat injured carotid arteries. Arterioscler Thromb Vasc Biol 29:488-494.
36. Peyton KJ, Reyna SV, Chapman GB, Ensenat D, Liu XM, Wang H, Schafer AI, and Durante W (2002) Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99:4443-4448. (Pubitemid 34627213)
37. Peyton KJ, Yu Y, Yates B, Shebib AR, Liu XM, Wang H, and Durante W (2011) Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion. J Pharmacol Exp Ther 338:476-484.
38. Rattan R, Giri S, Singh AK, and Singh I (2005) 5-Aminoimidazole-4- carboxamide-1-β-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem 280:39582-39593. (Pubitemid 41713917)
39. Reihill JA, Ewart MA, and Salt IP (2011) The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and -B in human aortic endothelial cells. Vasc Cell 3:9.
40. Ruscica M, Dozio E, Steffani L, Passafaro L, Mazzer M, Castellano JM, Motta M, Tena-Sempere M, and Magni P (2011) Role of the energy sensor adenosine monophosphate-activated protein kinase in the regulation of immature gonadotropin-releasing hormone neuron migration. J Endocrinol Invest 34:e362-e368.
41. Short JD, Dere R, Houston KD, Cai SL, Kim J, Bergeron JM, Shen J, Liang J, Bedford MT, Mills GB, et al. (2010) AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability. Mol Carcinog 49:429-439.
42. SimóR, Carrasco E, García-Ramírez M, and Hernández C (2006) Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2:71-98.
43. Sluimer JC and Daemen MJ (2009) Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 218:7-29.
44. Song P, Wang S, He C, Wang S, Liang B, Viollet B, and Zou MH (2011) AMPKα deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells. Circ Res 109:1230-1239.
45. Stahmann N, Woods A, Spengler K, Heslegrave A, Bauer R, Krause S, Viollet B, Carling D, and Heller R (2010) Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase. J Biol Chem 285:10638-10652.
46. Su KH, Yu YB, Hou HH, Zhao JF, Kou YR, Cheng LC, Shyue SK, and Lee TS (2012) AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase. J Cell Physiol 227:3053-3062.
47. Viana R, Aguado C, Esteban I, Moreno D, Viollet B, Knecht E, and Sanz P (2008) Role of AMP-activated protein kinase in autophagy and proteasome function. Biochem Biophys Res Commun 369:964-968.
48. Wang W, Fan J, Yang X, Fürer-Galban S, Lopez de Silanes I, von Kobbe C, Guo J, Georas SN, Foufelle F, Hardie DG, et al. (2002) AMP-activated kinase regulates cytoplasmic HuR. Mol Cell Biol 22:3425-3436.
49. Wei Y, Liu XM, Peyton KJ, Wang H, Johnson FK, Johnson RA, and Durante W (2009) Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival. Am J Physiol Cell Physiol 297:C907-C915.
50. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, et al. (2011) Structure of mammalian AMPK and its regulation by ADP. Nature 472:230-233.
51. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174. (Pubitemid 32995375)
52. Zou MH and Wu Y (2008) AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin Exp Pharmacol Physiol 35:535-545.